Document is current
Any future updates will be listed below
-
Authors
Goodman, Michelle S.
Trevizol, Alisson P.
Konstantinou, Gerasimos N. https://orcid.org/0000-0002-0303-1633
Boivin-Lafleur, David
Brender, Ram
Downar, Jonathan
Kaster, Tyler S. https://orcid.org/0000-0002-5299-4794
Knyahnytska, Yuliya
Vila-Rodriguez, Fidel
Voineskos, Daphne
Daskalakis, Zafiris J.
Blumberger, Daniel M. https://orcid.org/0000-0002-8422-5818
-
Funding
Funding for this research was provided by:
Innovation Fund of the Alternative Funding Plan for the Academic Health Sciences Centres of Ontario
- License Information
-
More Information
Article History
Received: 21 May 2024
Revised: 3 October 2024
Accepted: 8 October 2024
First Online: 23 October 2024
Competing interests
: DV holds the Labatt Family Professorship in Depression Biology, a University Named Professorship at the University of Toronto. She receives research support from CIHR, NIMH, the Center for Addiction and Mental Health (CAMH), The Center for Mental Health at University Health Network and the Department of Psychiatry at the University of Toronto. DV declares no biomedical interests or conflicts. FVR receives research support from CIHR, Brain Canada, Michael Smith Foundation for Health Research, Vancouver Coastal Health Research Institute, and Weston Brain Institute for investigator-initiated research. Philanthropic support from Seedlings Foundation. In-kind equipment support for investigator-initiated research from MagVenture. He has received honoraria for participation in an advisory board for Allergan. FVR is a volunteer director on the board of directors of the British Columbia Schizophrenia Society. TSK receives research support from the Canadian Institutes of Health Research, Patient-Centered Outcomes Research Institute, and the AFP Innovation Fund In the last 10 years, ZJD has received research and equipment in-kind support for an investigator-initiated study through Brainsway Inc and Magventure Inc. He also currently serves on the scientific advisory board for Brainsway Inc. His work has been supported by the National Institutes of Mental Health (NIMH), the Canadian Institutes of Health Research (CIHR), Brain Canada and the Temerty Family, Grant and Kreutzkamp Family Foundations. DMB receives research support from CIHR, NIH, Brain Canada and the Temerty Family through the CAMH Foundation and the Campbell Family Research Institute. He received research support and in-kind equipment support for an investigator-initiated study from Brainsway Ltd. He was the site principal investigator for three sponsor-initiated studies for Brainsway Ltd. He also received in-kind equipment support from Magventure for two investigator-initiated studies. He received medication supplies for an investigator-initiated trial from Indivior. He is a scientific advisor for Sooma Medical. He is the Co-Chair of the Clinical Standards Committee of the Clinical TMS Society (unpaid). The other authors declare no competing interests.
